Evaluating exposures to plants.
Most clinical problems due to plant exposures result from experimentation with or overt abuse of plant parts and extracts. Plant exposures may present as complex pharmacologic problems that challenge the diagnostic and therapeutic skills of the physician. Although specific physiologic antagonists (antidotes) may exist for specific intoxications, basic decontamination and supportive techniques are often all that may be offered.
D000328:Adult; D000470:Alkaloids / Q000633:toxicity; D001342:Autonomic Nervous System Diseases / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D002493:Central Nervous System Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003877:Dermatitis, Contact / Q000209:etiology; D004630:Emergencies; D005759:Gastroenteritis / Q000209:etiology; D006027:Glycosides / Q000633:toxicity; D006402:Hematologic Diseases / Q000209:etiology; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology; D019684:Magnoliopsida; D009821:Oils / Q000633:toxicity; D010936:Plant Extracts / Q000633:toxicity; D010939:Plant Poisoning / Q000150:complications / Q000175:diagnosis*; D010947:Plants, Toxic; D012116:Resins, Plant / Q000633:toxicity; D013634:Tannins / Q000633:toxicity
D000470:Alkaloids; D006027:Glycosides; D009821:Oils; D010936:Plant Extracts; D012116:Resins, Plant; D013634:Tannins